Look for:

Our offer for

POXEL S.A.


ISIN:
FR0012432516
WKN:
-

2023/09/25 09:10:01
Price
0.489 EUR
Difference 0.62% (0.00)

General attributes

ISINFR0012432516
SymbolPOXEL
ExchangeFrankfurt
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)17 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)0.489 EUR (6,135)
Ask (Ask size)0.499 EUR (6,013)
Open0.489 EUR
High0.489 EUR
Low0.489 EUR
Close (prev. day)0.486 EUR
VWAP0.526 EUR
Volume (pcs)0
Trading volume0.00
Number of trades3
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: POXEL S.A.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/09/25 09:10:01
Price
0.489 EUR
Difference 0.62% (0.00)

General attributes

ISINFR0012432516
SymbolPOXEL
ExchangeFrankfurt
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)17 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)0.489 EUR (6,135)
Ask (Ask size)0.499 EUR (6,013)
Open0.489 EUR
High0.489 EUR
Low0.489 EUR
Close (prev. day)0.486 EUR
VWAP0.526 EUR
Volume (pcs)0
Trading volume0.00
Number of trades3
Last size0

Performance and Risk

6M1Y3Y
Perf (%)-35.63%-70.58%-92.12%
Perf (abs.)-0.27-1.17-5.68
Beta0.980.700.95
Volatility46.1750.9751.10
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.490 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)0.559 EUR (1,097)
Ø price 100 days | Ø volume 100 days (pcs.)0.609 EUR (351)
Ø price 250 days | Ø volume 250 days (pcs.)0.855 EUR (305)
YTD High | date1.012 EUR (2023/01/25)
YTD Low | date0.484 EUR (2023/09/20)
52 Weeks High | date1.696 EUR (2022/09/23)
52 Weeks Low | date0.484 EUR (2023/09/20)

All listings for POXEL S.A.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Stuttgart2023/09/2509:030.486 EUR0.002
Munich2023/09/2508:040.531 EUR0.001
London Stock Exchange European Trade Reporting2023/09/2508:590.4975 EUR0.001
Frankfurt2023/09/2509:100.489 EUR0.003
FINRA other OTC Issues2023/08/0818:220.60 USD0.001
Euronext Paris2023/09/2509:040.4975 EUR0.0012
Berlin2023/09/2508:040.451 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=139372&ID_TYPE_IMAGE_LOGO=2

Contact Details

POXEL SA
- -
259/261, Avenue Jean Jaurès - 69007 Lyon
Telefon: +33-4-37-37-20-12
Fax: +33-4-37-70-88-15
E-mail: -

PDF Downloads

Annual report: POXEL S.A.PDF Download

Company Profile

Poxel SA operates as a clinical-stage biopharmaceutical company. The firm focuses on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as non-alcoholic steatohepatitis (NASH). Its drug candidates include Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH. The company was founded by Sébastien Bolze, Sophie Hallakou-Bozec, Pascale Fouqueray-Grellier, Pascale Malgouyres, and Thomas Kuhn on March 6, 2009 and is headquartered in Lyon, France.


Board of directors

Mohammed Khoso BaluchChairman of Supervisory Board
Pascale BoisselMember of Supervisory Board
Richard KenderMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.